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ABSTRACT
Introduction: There is a need to develop new, more
cost-effective models of healthcare and in this vein
there is a considerable international interest in
exploiting the potential offered by major developments
in health information technologies (HITs). Very
substantial investments are, as a result, now being
made globally, but these still probably only represent a
fraction of the investments needed if healthcare is to
make the transition from the paper to the digital era.
Investing greater resources is, however, inherently
challenging and unpopular at a time of financial
austerity and this is furthermore complicated by the
thus far variable evidence of health benefits and
demonstrable short-term to medium-term returns
associated with investments in HITs.
Objectives: Building on our related systematic
overviews investigating the impact of HITs, we now
seek to estimate the cost-effectiveness of HITs and as
a secondary aim to identify potentially transferable
lessons in relation to how to realise returns on
investments in these technologies.
Methods: We will conduct a systematic review to
identify the empirical evidence base surrounding the
return on investments from implementing HITs. Two
reviewers will independently search major international
databases for published, unpublished and on-going
experimental and quasi-experimental studies of interest
published during the period 1990–2013. These searches
of bibliographic databases will be supplemented by
contacting an international panel of experts. There will be
no restriction on the language of publication of studies.
Studies will be critically appraised using the Critical
Appraisal Skills Programme (CASP) Economic
Evaluations checklist. In view of the anticipated
heterogeneity in intervention investigated, study design
and health system contexts, we will undertake a
descriptive, narrative and interpretative synthesis of data.
Ethics and dissemination: Ethical approval is not
required.
Results: These will be presented in one manuscript. The
protocol is registered with the International Prospective
Register for Systematic Reviews (PROSPERO)
CRD42013005294.
INTRODUCTION
Health systems globally face substantial chal-
lenges associated with, among other issues,
rapidly changing demographic proﬁles (in
particular, ageing populations and the
reduced proportion of the population, ie,
economically active), increasing numbers of
people living with long-term conditions and
associated spiralling healthcare costs, and the
substantial, persistent variation in the quality
and safety of care provision.1 2
There is, in response to these challenges,
considerable policy interest in the potential
of health information technologies (HITs) to
support fundamental and far-reaching trans-
formations of health systems, but achieving
change on the scale required is, as our recent
work and that of others has clearly demon-
strated, challenging, time-consuming and
expensive.3–6 Policy makers are therefore
increasingly facing major challenges. These
include questions surrounding the justiﬁca-
tion of substantial investments in HIT, particu-
larly in times of austerity and unprecedented
cuts in public investment, and associated pres-
sures to achieve returns on investment in the
short to medium terms.7 8
For example, as in many other parts of the
world, the USA and the UK governments
have already committed to making the transi-
tion from paper-based health systems
to digital health economies.9 10 Substantial
investments have thus been made through
the Health Information Technology for
Economic and Clinical Health (HITECH)
Act in the USA and the National Programme
Strengths and limitations of this study
▪ We will systematically identify and critically
appraise the available evidence and grey literature
on this important policy question and identify
research in progress.
▪ The main limitations are those that are common
to all systematic reviews, namely the possibility
of failing to identify all relevant evidence and the
need to ensure that the synthesis of evidence is
appropriate and meaningful.
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for Information Technology (NPfIT) in the UK.11 These
however represent ﬁrst-wave investments in basic under-
pinning technologies and infrastructures associated with
electronic health record (EHR) functionality. Very sub-
stantial subsequent investments will be needed in order
to build on these infrastructures and utilise data held
within them to redesign health systems.4 12
Given these challenges, there is a pressing need to
better understand issues relating to the cost-effectiveness
of HITs and also to identify strategies of proven value in
enhancing economic returns on investments in HITs.
This systematic review builds on our recent systematic
overviews of the evidence investigating the impact of
HITs,4 13 and is the ﬁrst step in a related phased pro-
gramme of work investigating approaches to enhancing
returns on investments in HITs.
METHODS AND ANALYSIS
Design
We will undertake a systematic review of the published,
unpublished and in-progress empirical research
literature.
Eligibility criteria
Interventions of interest
We are interested in a broad range of HIT, which
include tools to support the management of data (eg,
EHRs), support and enhance clinical decision- making
(eg, computerised physician order entry and compu-
terised decision support systems) and provide care at a
distance (eg, telehealthcare).4 13 14
Study design
The following study designs will be potentially eligible
for inclusion:
▸ Systematic reviews, randomised controlled trials
(RCTs), quasi-RCTs, controlled clinical trials, con-
trolled before-after-studies, interrupted time series
and before-after or cohort type evaluations, under-
taken with formal health economic evaluations from
the perspective of healthcare providers.
▸ Economic modelling studies.
Outcome measures
▸ Primary outcome
– Estimates of the range of cost-effectiveness of HITs.
▸ Secondary outcomes
– Description of HITs that have been subjected to
formal economic evaluation, the geographical,
policy and clinical contexts in which these deploy-
ments have been made, the time frames over
which the economic evaluations have been under-
taken and the lessons learned.
– Insights into interventions that are potentially cost-
effective based on economic modelling studies.
Search methods
We will search the published empirical and grey litera-
ture from 1990 until 2013 for work investigating the
returns on investment in HITs. This start date has been
chosen to ensure that we capture the period when
policy makers particularly became interested in the
potential of HIT and also because the technologies that
existed before this time period are likely to have only
limited relevance to contemporary health systems.4 13
We will search the following major biomedical databases:
The Cochrane Library (and its associated databases,
namely: Cochrane Database of Systematic Reviews;
Cochrane Central Register of Controlled Trials
(CENTRAL); Cochrane Methodology Register; Database
of Abstracts of Reviews of Effects (DARE); Health
Technology Assessment Database; and the NHS
Economic Evaluation Database), MEDLINE, EMBASE,
Google Scholar, ClinicalTrials.gov and Current
Controlled Trials. Speciﬁc search strategies will be
employed for each database; an example of a search
strategy developed for MEDLINE is shown in online sup-
plementary appendix 1.
Study selection
Titles and abstracts of studies identiﬁed from the
searches will be checked by two investigators. The full
text of all retrieved potentially eligible studies will be
independently assessed against the above criteria by
these two investigators. The investigators will decide
which of the studies satisfy the inclusion criteria and the
methodological quality of eligible studies will be
recorded (discussed below). Any disagreements will be
resolved by discussion between the investigators, with
referral to a third member of the research team, if
necessary.
Quality assessment and analysis
Formal quality assessment of eligible studies will be inde-
pendently undertaken by two reviewers using the
Critical Appraisal Skills Programme Economic
Evaluations checklist.15 Disagreements will be resolved
through discussion, with arbitration by a third reviewer if
agreement cannot be reached through discussion.
Data extraction
Data will be abstracted onto a customised data extraction
sheet by two independent reviewers; any disagreements
will be resolved through discussion, with arbitration by a
third reviewer if necessary. Variables to be extracted will
include: author and year; title of the study; country of
origin; healthcare setting; HIT application(s); estimates
of costs and cost-effectiveness; time frame over which
evaluations are undertaken; lessons learned. Key ﬁnd-
ings from each study will be summarised and presented
in summary tables.
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Data analysis
A quantitative synthesis is likely to prove inappropriate
due to the heterogeneity of technologies, study designs
and care contexts. Data will therefore be descriptively
summarised and narratively synthesised. We will follow
four main steps in conducting an interpretive synthesis
of our ﬁndings: (1) noting the range of functions and
uses of existing systems; (2) developing a preliminary
synthesis of the ﬁndings of included studies; (3) explor-
ing relationships in the ﬁndings and (4) exploring the
potential transferability of ﬁndings to other contexts and
settings.16 There are likely to be challenges associated
with integrating heterogeneous data sources, due to for
example, differences in interventions studied, methods,
outcomes, study population and context.17 We will
attempt to address these by judging the relevance of het-
erogeneity, and the quality of evidence and consistency
of ﬁndings of included studies.17
Acknowledgements The authors wish to record their appreciation to Andrew
Stoddart, health economist at the Lothain Health Services Research Unit,
University of Edinburgh for his advice.
Contributors AS and DB conceived the idea for this study. AS developed the
methods, and together with UBN, KC and DB drafted this protocol.
Competing interests AS is supported by The Commonwealth Fund, a private
independent foundation based in New York City. The views presented here are
those of the author and not necessarily those of The Commonwealth Fund, its
directors, officers, or staff.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The systematic review protocol is registered with the
PROSPERO International Prospective Register of Systematic Reviews (http://
www.crd.york.ac.uk/prospero)18 CRD42013005294 and reported using
Preferred Reporting Items for Systematic Reviews and Meta-analysis
(PRISMA) guidelines19 in the peer-reviewed literature. The systematic review
will be in one manuscript and shared with others.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/3.0/
REFERENCES
1. Kohn LT, Corrigan JM, Donaldson MS. eds. To err is human: building
a safer health system. Washington: National Academy Press, 1999.
2. Institute of Medicine. Crossing the quality chasm: a new health
system for the 21st century. Washington, DC: National Academy
Press, 2001.
3. Chaudhry B, Wang J, Wu S, et al. Systematic review: impact of
health information technology on quality, efficiency, and costs of
medical care. Ann Intern Med 2006;144:742–52.
4. Black A, Car J, Beyer K, et al. The impact of eHealth on the quality
and safety of healthcare: a systematic overview of the literature.
PLoS Med 2011;8:e1000387.
5. Sheikh A, Cornford T, Barber N, et al. Implementation and adoption
of nationwide electronic health records in secondary care in
England: final qualitative results from prospective national evaluation
in “early adopter” hospitals. BMJ 2011;343:d6054.
6. Robertson A, Bates DW, Sheikh A. The rise and fall of England’s
National Programme for IT. J R Soc Med 2011;104:434–5.
7. Robertson A, Cornford T, Barber N, et al.; NHS Care Records
Service Evaluation Team. The NHS IT project: more than just a bad
dream. Lancet 2012;379:29–30.
8. Cresswell K, Sheikh A. Electronic health record technology. JAMA
2012;307:2255–6.
9. Blumenthal D. Wiring the health system—origins and provisions of a
new federal program. N Engl J Med 2011;365:2323–9.
10. Department of Health. Delivering 21st century IT support for the NHS:
national strategic programme. London: Department of Health, 2002.
11. Morrison Z, Robertson A, Cresswell K, et al. Understanding
contrasting approaches to nationwide implementations of electronic
health record systems: England, the USA and Australia.
J Healthcare Eng 2011;2:25–41.
12. Bitton A, Flier LA, Jha AK. Health information technology in the era
of care delivery reform: to what end? JAMA 2012;307:2593–4.
13. McLean S, Sheikh A, Cresswell K, et al. The impact of
telehealthcare on the quality and safety of care: a systematic
overview. PLoS ONE 2013;8:e71238.
14. Haas P, Sembritzki J. The European eHealth initative—objectives
and solutions. European eHealth Initiative: http://subs.emis.de/LNI/
Proceedings/Proceedings91/GI-Proceedings-91-2.pdf (accessed
29 Jul 2013).
15. Critical Appraisal Skills Programme. http://www.casp-uk.net/wp-
content/uploads/2011/11/CASP-Economic-Evaluations-Checklist-31.
05.13.pdf (accessed 29 Jul 2013).
16. Cresswell K, Majeed A, Bates DW, et al. Computerised decision
support systems for healthcare professionals: an interpretative
review. Inform Prim Care 2012;20:115–28.
17. Mulrow C, Langhorne P, Grimshaw J. Integrating heterogeneous
pieces of evidence in systematic reviews. Ann Intern Med
1997;127:989–95.
18. PROSPERO. http://www.crd.york.ac.uk/prospero (assessed 29 Jul
2013).
19. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for
reporting systematic reviews and meta-analyses of studies that
evaluate health care interventions: explanation and elaboration.
PLoS Med 2009;6:e1000100.
Sheikh A, Nurmatov UB, Cresswell K, et al. BMJ Open 2013;3:e003737. doi:10.1136/bmjopen-2013-003737 3
Open Access
